American
College of
Epidemiology 2001 Election
Results

ACE President-Elect

CAROL J. ROWLAND HOGUE, Ph.D, MPH, is the Terry Professor of Maternal and Child Health and Professor of Epidemiology in the Rollins School of Public Health at Emory University.

BACKGROUND: Hogue conducts research on disparities in women's and infants' health. She received her MPH and PhD in Epidemiology at the University of North Carolina and subsequently was Assistant Professor of Biostatistics at UNC (1974-77). She was a member of the Biometry faculty at the University of Arkansas for Medical Sciences (Assistant then Associate Professor, 1977-82) and consultant to the National Center for Toxicologic Research. In 1982, she went to the Centers for Disease Control, where she was Chief of the Pregnancy and Infant Health Branch (1982-88) and Director of the Division of Reproductive Health (1988-92) in the National Center for Disease Prevention and Health Promotion, prior to returning to academia in 1992 in her present position at Emory University. During her tenure at CDC, she helped establish both national birth/death record linkage analysis and the Pregnancy Risk Assessment Monitoring System (PRAMS), as well as to maintain abortion surveillance. Hogue served on the Institute of Medicine Committee on Unintended Pregnancy, several National Institutes of Health committees and sits on several editorial boards, including the Journal of the National Medical Women’s Association. She has served as an advisor to the World Health Organization, the Pan American Health Organization, and the Latin American Perinatal Center. Hogue is a founding fellow of the American College of Epidemiology, has served on its membership and education committees, and is currently a member of the Board of Directors. She has been president of the Society for Epidemiologic Research, Chair of the MCH Council for the Association of Schools of Public Health, is a fellow of the American Epidemiological Society, and a member of the Epidemic Intelligence Service alumni association.


Board of Directors

ROGER H. BERNIER, Ph.D, MPH, is Associate Director for Science, National Immunization Program, Centers for Disease Control and Prevention (full time) and Editor, The Epidemiology Monitor (part time).

BACKGROUND: Bernier received a BA degree in 1966 from Assumption College in Worcester, Massachusetts, an MPH from Yale University in 1974, and a PhD in epidemiology from the Johns Hopkins University in 1978. He began working for CDC immediately after undergraduate school with assignments to the Venereal Disease Program in New York City and to the Smallpox Eradication and Measles Control program in Niger, West Africa. Following these public health field assignments and his subsequent academic training in epidemiology, Bernier rejoined CDC as part of CDC’s Epidemic Intelligence Service. He started in the National Immunization Program where he has remained as a staff epidemiologist, then as Chief of the Epidemiologic Research Section, and most recently as Associate Director for Science.

Bernier’s career has focused on epidemiologic studies of the safety and efficacy of new and existing vaccines, factors linked to vaccine coverage and improving vaccination coverage levels, and assessments of controversial hypotheses about vaccine safety. In his present position, Bernier is responsible for assuring the quality of the scientific work carried out by scientists in the National Immunization Program. As the senior scientific advisor to the Director of the program, he addresses a broad range of scientific, methodologic, and science-related policy issues. Most recently, he helped lead the Public Health Service’s initial assessment and wrote the HHS policy statement on the controversy surrounding the relationship between thimerosal, a mercury-containing preservative in vaccines, and neurodevelopmental health effects. He has also envisioned and helped create a new type of committee within the Institute of Medicine that will be providing ongoing reviews of vaccine safety issues of widespread public concern. Bernier has received honors and awards for his work over the years and he is currently a member of several epidemiology associations (ACE, AES, APHA, IEA, ISEE, ISPE, and SER).

BETSY FOXMAN, Ph.D., is Professor of Epidemiology and Director of the Center for Molecular and Clinical Epidemiology of Infectious Diseases (MAC-EPID) at the University of Michigan School of Public Health.

BACKGROUND: Dr. Foxman is a molecular epidemiologist whose interest is in the transmission, evolution and pathogenesis of infectious diseases. Her research focuses on highly prevalent, multi-agent infectious diseases with an acute, chronically recurring nature. She has ongoing studies of urinary tract infection, vulvo-vaginal candidiasis, otitis media and group B streptococcus. Foxman earned Masters' and doctoral degrees in Epidemiology from the University of California Los Angeles. She has been on the faculty of the Department of Epidemiology at the University of Michigan since 1987. In 1996, she was elected a fellow of the Infectious Disease Society of America. She is founding director of the Center for Molecular and Clinical Epidemiology of Infectious Diseases (MAC-EPID). She has served as section councilor and as chair of the American Public Health Association (APHA) Epidemiology Section. She was one of the APHA representatives on the program planning committee for the 2001 North American Congress of Epidemiology, and organized and chaired a meeting of the leadership of 16 epidemiology societies held in conjunction with the Congress. Foxman has been principal investigator on several NIH grants, is an associate editor of the American Journal of Epidemiology and serves on the editorial board of the Human Genome Epidemiology Network (HuGE Net). She also serves on the executive board of the Michigan Antibiotic Resistance Reduction (MARR) coalition, a community- based coalition whose mission is to decrease inappropriate use of antimicrobial agents and antimicrobial resistance rates through the collaborative efforts of academic, community, government, and industry partners.

ROSANNE B. MCTYRE, Ph.D. heads the epidemiology and biostatistics practice at THE WEINBERG GROUP INC., a scientific consulting firm in Washington, DC.

BACKGROUND: Dr. McTyre received a B.A. in Biology from Swarthmore College, an M.P.H. from Yale University School of Medicine, Department of Epidemiology and Public Health in infectious disease epidemiology, and a Ph.D. from The Johns Hopkins School of Hygiene and Public Health in chronic disease epidemiology. During the last 20 years she has served as a consultant both for government and private clients on a wide variety of subject areas including environmental/occupational exposures, health care products, implanted medical devices and pharmaceuticals. Dr. McTyre is an active member of the Society for Epidemiology Research and the American College of Epidemiology. She is presently completing a three-year term on the Board of Directors of the American College of Epidemiology, and serves as Co-Chair of the Education Committee. She is a past member of the Ethics and Standards of Practice Committee, where she participated in the writing of ethics guidelines for the College.


COLIN L. SOSKOLNE, BSc, BSc Hons, PhD, is Professor of Epidemiology and Graduate Coordinator in the Department of Public Health Sciences, University of Alberta, Edmonton, Canada.

BACKGROUND: Dr. Soskolne initially trained in applied mathematics and computer science in South Africa. His first job was as statistician with the South African Human Sciences Research Council. He then directed the Transvaal Branch of the Medical Research Council’s Institute for Statistical Research associated with the National Research Institute for Occupational Diseases, Johannesburg. He left South Africa for a January 1978 start in a PhD program in Epidemiology at the University of Pennsylvania, Philadelphia. In 1982, he joined the Ontario Cancer Foundation as Director of its Epidemiology Research Unit located in the Department of Preventive Medicine and Biostatistics at the University of Toronto. There he was heavily engaged in AIDS research, in both professional and public education, and in advocacy about AIDS. He was awarded the SER 1983 Student Prize for his doctoral work. He joined the University of Alberta in 1985. There, he established the Department of Public Health Sciences’ Epidemiology Program, and both built and directed the Department’s graduate training program. His major research contribution formed the basis in 1991 for the International Agency for Research on Cancer designating "occupational exposures to strong-inorganic-acid mists containing sulfuric acid" as a definitive human carcinogen. From 1984 to 1996, he spearheaded efforts to bring the question of professional ethics into focus for epidemiologists worldwide. He served on the ACE Ethics and Standards of Practice Committee for its first 10 years of operation through which he contributed significantly to the development and recent publication of the ACE ethics guidelines. His membership in ACE goes back to its founding days, and he has been a Fellow since 1988. His most recent sabbatical was with the WHO’s European Centre for Environment and Health, Rome. There, he produced a discussion document concerned with the linkages between global ecological integrity and sustainable development. He has successfully organized several national and international conferences. He has won awards for his professional service. He currently is an elected Councilor on the Board of the International Society for Environmental Epidemiology (ISEE) which three-year term expires later in 2001, allowing for a seamless transition to ACE. His name is associated with over 200 published works. His home page URL is: http://www